Twist Bioscience to Present at Upcoming Virtual Conferences

Rhea-AI Summary

Twist Bioscience Corporation (NASDAQ: TWST) has announced that CEO Emily Leproust, Ph.D., and CFO Jim Thorburn will present at several virtual investor conferences. The presentations include the SVB Leerink 10th Annual Global Healthcare Conference on February 26 at 11:20 a.m. ET, the Cowen 41st Annual Healthcare Conference on March 4 at 1:30 p.m. ET, and the Barclays Global Healthcare Conference on March 9 at 10:20 a.m. ET. These fireside chats will be webcast live and available for 30 days afterwards. Twist Bioscience is known for its innovative synthetic DNA technology.

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that Emily Leproust, Ph.D., CEO and co-founder of Twist Bioscience, and Jim Thorburn, CFO of Twist Bioscience, will present at the following upcoming virtual investor conferences:

• SVB Leerink 10^th Annual Global Healthcare Conference on Friday, February 26; fireside chat at 11:20 a.m. Eastern Time.
• Cowen 41^st Annual Healthcare Conference on Thursday, March 4; fireside chat at 1:30 p.m. Eastern Time, and Synthetic Biology CEO Panel at 2:50 p.m. Eastern Time.
• Barclays Global Healthcare Conference on Tuesday, March 9; fireside chat at 10:20 a.m. Eastern Time.

The fireside chats will be webcast live and can be accessed by visiting the “Investor Calendar” page of the investor relations section of the company's website here. A replay of the fireside chats will be archived for a period of 30 days following conclusion of the live events.

About Twist Bioscience Corporation

Twist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of the platform is a proprietary technology that pioneers a new method of manufacturing synthetic DNA by “writing” DNA on a silicon chip. Twist is leveraging its unique technology to manufacture a broad range of synthetic DNA-based products, including synthetic genes, tools for next-generation sequencing (NGS) preparation, and antibody libraries for drug discovery and development. Twist is also pursuing longer-term opportunities in digital data storage in DNA and biologics drug discovery. Twist makes products for use across many industries including healthcare, industrial chemicals, agriculture and academic research.

Follow us on Twitter | Facebook | LinkedIn | YouTube

View source version on businesswire.com: https://www.businesswire.com/news/home/20210219005129/en/

FAQ

When will Twist Bioscience present at the SVB Leerink 10th Annual Global Healthcare Conference?

Twist Bioscience will present at the SVB Leerink 10th Annual Global Healthcare Conference on February 26 at 11:20 a.m. Eastern Time.

What is the schedule for Twist Bioscience’s presentations at investor conferences in March 2021?

In March 2021, Twist Bioscience will present at the Cowen 41st Annual Healthcare Conference on March 4 at 1:30 p.m. ET and at the Barclays Global Healthcare Conference on March 9 at 10:20 a.m. ET.

How can I access the live webcasts of Twist Bioscience’s presentations?

The live webcasts of Twist Bioscience's presentations can be accessed through the 'Investor Calendar' page on their investor relations website.

What is the nature of the technology developed by Twist Bioscience?

Twist Bioscience has developed a disruptive DNA synthesis platform that uses a silicon chip to manufacture synthetic DNA.

What industries does Twist Bioscience cater to with its products?

Twist Bioscience's products cater to various industries including healthcare, agriculture, industrial chemicals, and academic research.